A native of Sweden, Helena Cowley moved to the U.S. in 2009 as a teenager. She is the CEO of Captozyme, a company that developed an enzyme to degrade oxalates, a key component of kidney stones and possibly the source of other problems for the body.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
